From bench side to clinic: Potential and challenges of RNA vaccines and therapeutics in infectious diseases-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

From bench side to clinic: Potential and challenges of RNA vaccines and therapeutics in infectious diseases

Published:2021-10 Issue: Volume:81 Page:101003
ISSN:0098-2997
Container-title:Molecular Aspects of Medicine
language:en
Short-container-title:Molecular Aspects of Medicine

Author:

Pandey Manish,Ojha Divya,Bansal Sakshi,Rode Ambadas B.,Chawla Geetanjali^ORCID

Funder

Department of Science and Technology, Ministry of Science and Technology, India

The Wellcome Trust DBT India Alliance

Department of Biotechnology, Ministry of Science and Technology, India

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Molecular Biology,Molecular Medicine,General Medicine,Biochemistry

Reference459 articles.

1. FDA approves eteplirsen for duchenne muscular dystrophy: the next chapter in the eteplirsen saga;Aartsma-Rus;Nucleic Acid Therapeut.,2017

2. Toxicological and pharmacokinetic properties of QPI-1007, a chemically modified synthetic siRNA targeting caspase 2 mRNA, following intravitreal injection;Nucleic Acid Therapeut.,2014

3. Development of exon skipping therapies for duchenne muscular dystrophy: a critical review and a perspective on the outstanding issues;Aartsma-Rus;Nucleic Acid Therapeut.,2017

4. Development of CRISPR as an antiviral strategy to combat SARS-CoV-2 and influenza;Abbott;Cell,2020

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exosome for mRNA delivery: strategies and therapeutic applications;Journal of Nanobiotechnology;2024-07-04

2. Medicinal Chemistry of Antisense Oligonucleotides for Therapeutic Use in SARS-CoV-2: Design Strategies and Challenges for Targeted Delivery;Current Medicinal Chemistry;2024-06-11

3. RNA-Based Vaccines and Therapeutics Against Intracellular Pathogens;Methods in Molecular Biology;2024

4. Creation of Architecturally Minimal Transcriptionally Activating Riboswitches Responsive to Theophylline Reveals an Unconventional Design Strategy;ACS Synthetic Biology;2023-12-05

5. Development of microRNA-based therapeutics for central nervous system diseases;European Journal of Pharmacology;2023-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3